Article

A Deep Learning Proteomic Scale Approach for Drug Design

2021-10-06

Abstract excerpt

Computational approaches have accelerated novel therapeutic discovery in recent decades. The Computational Analysis of Novel Drug Opportunities (CANDO) platform for shotgun multi-target therapeutic discovery, repurposing, and design aims to improve their efficacy and safety by employing a holistic approach by computing interaction signatures between every drug/compound and a large library of non-redundant protein...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f011014a-4a58-5162-be99-dfcfe9d35988
DOI: 10.1101/2021.10.05.463126

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Deep Learning Proteomic Scale Approach for Drug DesignDOI 10.1101/2021.10.05.463126Read

De novo drug design based on patient gene expression profiles via deep learningSemantic proximity Read

Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO PlatformSemantic proximity Read

Multiscale virtual screening optimization for shotgun drug repurposing using the CANDO platformSemantic proximity Read

DR3E-Net: Drug Repurposing Network Framework Based on Deep Embedding, Differentially Expressed Genes, and Drug Side EffectsSemantic proximity Read

Effective holistic characterization of small molecule effects using heterogeneous biological networksSemantic proximity Read

Multilayered validation of graph attention autoencoder–derived drug repurposing candidates for COVID-19Semantic proximity Read

Novel graph attention autoencoder framework with multilayered validation identifies drug repurposing candidates for COVID-19 treatmentSemantic proximity Read

Identifying Protein Features Responsible for Improved Drug Repurposing Accuracies Using The CANDO Platform: Implications for Drug DesignSemantic proximity Read

A deep learning framework for high-throughput mechanism-driven phenotype compound screeningSemantic proximity Read

Artificial Intelligence in Drug Discovery: A New Paradigm from Target Identification to Clinical TranslationSemantic proximity Read

Identification of targets for drug repurposing to treat COVID-19 using a Deep Learning Neural NetworkSemantic proximity Read

Creating a Novel Deep Learning Pipeline to Generate and Screen Molecules for Hormone-Positive Breast Cancer TreatmentSemantic proximity Read